| Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. RG Verhaak, KA Hoadley, E Purdom, V Wang, Y Qi, MD Wilkerson, ... Cancer Cell 17 (1), 98-110, 2010 | 8270 | 2010 |
| miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells J Silber, DA Lim, C Petritsch, AI Persson, AK Maunakea, M Yu, ... BMC medicine 6, 1-17, 2008 | 1161 | 2008 |
| Genes for Epidermal Growth Factor Receptor, Transforming Growth Factor α, and Epidermal Growth Factor and Their Expression in Human Gliomas in Vivo AJ Ekstrand, CD James, WK Cavenee, B Seliger, RF Pettersson, ... Cancer research 51 (8), 2164-2172, 1991 | 862 | 1991 |
| Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas L Frederick, XY Wang, G Eley, CD James Cancer research 60 (5), 1383-1387, 2000 | 856 | 2000 |
| Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. J Reifenberger, G Reifenberger, L Liu, CD James, W Wechsler, ... The American journal of pathology 145 (5), 1175, 1994 | 804 | 1994 |
| Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N-and/or C-terminal tails. AJ Ekstrand, N Sugawa, CD James, VP Collins Proceedings of the National Academy of Sciences 89 (10), 4309-4313, 1992 | 791 | 1992 |
| Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. N Sugawa, AJ Ekstrand, CD James, VP Collins Proceedings of the National Academy of Sciences 87 (21), 8602-8606, 1990 | 766 | 1990 |
| PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme JS Smith, I Tachibana, SM Passe, BK Huntley, TJ Borell, N Iturria, ... Journal of the National Cancer Institute 93 (16), 1246-1256, 2001 | 759 | 2001 |
| The histone H3. 3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression KM Chan, D Fang, H Gan, R Hashizume, C Yu, M Schroeder, N Gupta, ... Genes & development 27 (9), 985-990, 2013 | 725 | 2013 |
| A hierarchy of self-renewing tumor-initiating cell types in glioblastoma R Chen, MC Nishimura, SM Bumbaca, S Kharbanda, WF Forrest, ... Cancer cell 17 (4), 362-375, 2010 | 710 | 2010 |
| Sporadic Medulloblastomas Contain PTCH Mutations C Raffel, RB Jenkins, L Frederick, D Hebrink, B Alderete, DW Fults, ... Cancer research 57 (5), 842-845, 1997 | 706 | 1997 |
| Clonal genomic alterations in glioma malignancy stages CD James, E Carlbom, JP Dumanski, M Hansen, M Nordenskjold, ... Cancer research 48 (19), 5546-5551, 1988 | 690 | 1988 |
| Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA DA Nathanson, B Gini, J Mottahedeh, K Visnyei, T Koga, G Gomez, ... Science 343 (6166), 72-76, 2014 | 643 | 2014 |
| An overview of meningiomas RA Buerki, CM Horbinski, T Kruser, PM Horowitz, CD James, RV Lukas Future Oncology 14 (21), 2161-2177, 2018 | 571 | 2018 |
| Mutational inactivation of STAG2 causes aneuploidy in human cancer DA Solomon, T Kim, LA Diaz-Martinez, J Fair, AG Elkahloun, BT Harris, ... Science 333 (6045), 1039-1043, 2011 | 568 | 2011 |
| Evidence for Sequenced Molecular Evolution of IDH1 Mutant Glioblastoma From a Distinct Cell of Origin A Lai, S Kharbanda, WB Pope, A Tran, OE Solis, F Peale, WF Forrest, ... Journal of clinical oncology 29 (34), 4482-4490, 2011 | 547 | 2011 |
| Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma R Hashizume, N Andor, Y Ihara, R Lerner, H Gan, X Chen, D Fang, ... Nature medicine 20 (12), 1394-1396, 2014 | 494 | 2014 |
| An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR–dependent pathway D Guo, F Reinitz, M Youssef, C Hong, D Nathanson, D Akhavan, D Kuga, ... Cancer discovery 1 (5), 442-456, 2011 | 478 | 2011 |
| Mechanisms of chemoresistance to alkylating agents in malignant glioma JN Sarkaria, GJ Kitange, CD James, R Plummer, H Calvert, M Weller, ... Clinical cancer research 14 (10), 2900-2908, 2008 | 460 | 2008 |
| Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts GJ Kitange, BL Carlson, MA Schroeder, PT Grogan, JD Lamont, ... Neuro-oncology 11 (3), 281-291, 2009 | 445 | 2009 |
Rintaro HashizumeAssociate Professor of Department of Pediatrics, UABuab.edu의 이메일 확인됨
